Does Bionano Genomics Deserve a Place in Your Portfolio?

This post was originally published on this site

Located in lovely San Diego, BNGO was founded in 2003. BNGO’s novel gene diagnostic technology is certainly generating plenty of attention from Wall Street traders. However, those who take a close look at BNGO’s long-term chart are rightfully concerned that the stock might be overvalued.

Has BNGO climbed too high too quickly? Will profits be taken off the table, sending the stock lower in the weeks and months ahead? Let’s take a look at whether BNGO has the merits necessary to justify a position in your portfolio.

Continue reading on StockNews

Add Comment